In humans, TRIB3 has also been associated with insulin resistance and T2DM, accompanied by enhanced inhibition of insulin signalling and AKT/PKB activation in different tissues, including the β cells [61,67,68]. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.